Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 6, 2006 - Issue 1
Submit an article Journal homepage
610
Views
96
CrossRef citations to date
0
Altmetric
Review

Adenovirus p53 gene therapy

Jack A Roth UT M. D. Anderson Cancer Center, Department of Thoracic and Cardiovascular Surgery, Unit 445, P.O. Box 301402, Houston, TX 77230-1402, USA. [email protected]
Pages 55-61 | Published online: 22 Dec 2005

Citations (96)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Tao Guo, Xue Dong, Shanli Xie, Ling Zhang, Peibin Zeng & Lin Zhang. (2021) Cellular Mechanism of Gene Mutations and Potential Therapeutic Targets in Ovarian Cancer. Cancer Management and Research 13, pages 3081-3100.
Read now
Jason M Beckta, Syed Farhan Ahmad, Hu Yang & Kristoffer Valerie. (2014) Revisiting p53 for cancer-specific chemo- and radiotherapy. Cell Cycle 13:5, pages 710-713.
Read now
Hiroshi Tazawa, Shunsuke Kagawa & Toshiyoshi Fujiwara. (2013) Advances in adenovirus-mediated p53 cancer gene therapy. Expert Opinion on Biological Therapy 13:11, pages 1569-1583.
Read now
Steve H Thorne. (2007) Strategies to achieve systemic delivery of therapeutic cells and microbes to tumors. Expert Opinion on Biological Therapy 7:1, pages 41-51.
Read now

Articles from other publishers (92)

Mohammad Ejaz, Maria Rukan, Laiba Hassan, Hafiz Muhammad Waqas Munir, Muhammad Ali Syed & Rani Faryal. 2023.
Zeenat Farooq, Shahnawaz Wani, Vijay Avin Balaji Ragunathrao, Rakesh Kochhar & Mumtaz Anwar. 2022. p53 - A Guardian of the Genome and Beyond. p53 - A Guardian of the Genome and Beyond.
Maryam Nurzadeh, Mahsa Naemi & Shahrzad Sheikh Hasani. (2021) A comprehensive review on oncogenic miRNAs in breast cancer. Journal of Genetics 100:1.
Crossref
Juliana G. Xande, Ana P. Dias, Rodrigo E. Tamura, Mario C. Cruz, Bárbara Brito, Robledo A. Ferreira, Bryan E. Strauss & Eugenia Costanzi-Strauss. (2019) Bicistronic transfer of CDKN2A and p53 culminates in collaborative killing of human lung cancer cells in vitro and in vivo. Gene Therapy 27:1-2, pages 51-61.
Crossref
Guillermina Lozano. (2019) Restoring p53 in cancer: the promises and the challenges. Journal of Molecular Cell Biology 11:7, pages 615-619.
Crossref
Chiraz Atri, Fatma Z. Guerfali & Dhafer Laouini. 2019. AGO-Driven Non-Coding RNAs. AGO-Driven Non-Coding RNAs 137 177 .
Shu-Yi Ho, Bo-Hau Chang, Chen-Han Chung, Yu-Ling Lin, Cheng-Hsun Chuang, Pei-Jung Hsieh, Wei-Chih Huang, Nu-Man Tsai, Sheng-Chieh Huang, Yen-Ku Liu, Yu-Chih Lo & Kuang-Wen Liao. (2018) Development of a computational promoter with highly efficient expression in tumors. BMC Cancer 18:1.
Crossref
Katie S. Murray, Massimiliano Spaliviero, Emily S. Tonorezos, Mario E. Lacouture, William D. Tap, Kevin C. Oeffinger, Hebert Alberto Vargas & James A. Eastham. (2018) Li-Fraumeni Syndrome-related Malignancies Involving the Genitourinary Tract: Review of a Single-institution Experience. Urology 119, pages 55-61.
Crossref
Nayer Hosseinahli, Mahyar Aghapour, Pascal H. G. Duijf & Behzad Baradaran. (2018) Treating cancer with microRNA replacement therapy: A literature review. Journal of Cellular Physiology 233:8, pages 5574-5588.
Crossref
Sergiu Chira, Diana Gulei, Amin Hajitou & Ioana Berindan-Neagoe. (2018) Restoring the p53 ‘Guardian’ Phenotype in p53-Deficient Tumor Cells with CRISPR/Cas9. Trends in Biotechnology 36:7, pages 653-660.
Crossref
Connie A. LarssonSydney M. Moyer, Bin LiuKeith A. MichelVinod PantPeirong YangJustin WongAdel K. El-Naggar, Ralf KraheGuillermina Lozano. (2018) Synergistic and additive effect of retinoic acid in circumventing resistance to p53 restoration. Proceedings of the National Academy of Sciences 115:9, pages 2198-2203.
Crossref
Peng Gao, Nicole A. Seebacher, Francis Hornicek, Zheng Guo & Zhenfeng Duan. (2018) Advances in sarcoma gene mutations and therapeutic targets. Cancer Treatment Reviews 62, pages 98-109.
Crossref
Brandon L. Helfield, Xucai Chen, Bin Qin, Simon C. Watkins & Flordeliza S. Villanueva. (2017) Mechanistic Insight into Sonoporation with Ultrasound-Stimulated Polymer Microbubbles. Ultrasound in Medicine & Biology 43:11, pages 2678-2689.
Crossref
Cody S. Lee, Elliot S. Bishop, Ruyi Zhang, Xinyi Yu, Evan M. Farina, Shujuan Yan, Chen Zhao, Zongyue Zeng, Yi Shu, Xingye Wu, Jiayan Lei, Yasha Li, Wenwen Zhang, Chao Yang, Ke Wu, Ying Wu, Sherwin Ho, Aravind Athiviraham, Michael J. Lee, Jennifer Moriatis Wolf, Russell R. Reid & Tong-Chuan He. (2017) Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine. Genes & Diseases 4:2, pages 43-63.
Crossref
Yogesh R. Suryawanshi, Tiantian Zhang & Karim Essani. (2017) Oncolytic viruses: emerging options for the treatment of breast cancer. Medical Oncology 34:3.
Crossref
Qi Xie, Min-Yi Wu, Ding-Xuan Zhang, Yi-Ming Yang, Bao-Shuai Wang, Jing Zhang, Jin Xu, Wei-De Zhong & Jia-Ni Hu. (2016) Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo . World Journal of Gastroenterology 22:32, pages 7342.
Crossref
O. A. Bezborodova, E. R. Nemtsova, R. I. Yakubovskaya & A. D. Kaprin. (2016) Gene therapy is a new area in medicine. Onkologiya. Zhurnal imeni P.A.Gertsena 5:2, pages 64.
Crossref
Ellen Weisberg, Ensar Halilovic, Vesselina G. Cooke, Atsushi Nonami, Tao Ren, Takaomi Sanda, Irene Simkin, Jing Yuan, Brandon Antonakos, Louise Barys, Moriko Ito, Richard Stone, Ilene Galinsky, Kristen Cowens, Erik Nelson, Martin Sattler, Sebastien Jeay, Jens U. Wuerthner, Sean M. McDonough, Marion Wiesmann & James D. Griffin. (2015) Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097. Molecular Cancer Therapeutics 14:10, pages 2249-2259.
Crossref
Evrim Gurpinar & Karen H. Vousden. (2015) Hitting cancers’ weak spots: vulnerabilities imposed by p53 mutation. Trends in Cell Biology 25:8, pages 486-495.
Crossref
Hui Yin, Feng Zhao, Daohai Zhang & Jun Li. (2015) Hyaluronic acid conjugated β-cyclodextrin-oligoethylenimine star polymer for CD44-targeted gene delivery. International Journal of Pharmaceutics 483:1-2, pages 169-179.
Crossref
Cheng Ai, Rujian Jiang, Li Fu & Youdong Chen. (2014) RETRACTED ARTICLE: MicroRNA-495 mimics delivery inhibits lung tumor progression. Tumor Biology 36:2, pages 729-735.
Crossref
Michael J. Duffy, Naoise C. Synnott, Patricia M. McGowan, John Crown, Darran O’Connor & William M. Gallagher. (2014) p53 as a target for the treatment of cancer. Cancer Treatment Reviews 40:10, pages 1153-1160.
Crossref
Josefa A. Rodríguez, Lina M. Martínez, Nataly Cruz & Alba L. Cómbita. (2014) Terapia génica para el tratamiento del cáncer. Revista Colombiana de Cancerología 18:1, pages 27-40.
Crossref
Hong Xie, Jia Hu, Huan Pan, Yaxin Lou, Ping Lv & Yingyu Chen. (2014) Adenovirus vector-mediated FAM176A overexpression induces cell death in human H1299 non-small cell lung cancer cells. BMB Reports 47:2, pages 104-109.
Crossref
Shruti Koulgi, Archana Achalere, Neeru Sharma, Uddhavesh Sonavane & Rajendra Joshi. (2013) QM-MM simulations on p53-DNA complex: a study of hot spot and rescue mutants. Journal of Molecular Modeling 19:12, pages 5545-5559.
Crossref
Cedric M. Panje, David S. Wang & Jürgen K. Willmann. (2013) Ultrasound and Microbubble–Mediated Gene Delivery in Cancer. Investigative Radiology 48:11, pages 755-769.
Crossref
Chinthalapally V. Rao, Jagan Mohan R. Patlolla, Li Qian, Yuting Zhang, Misty Brewer, Altaf Mohammed, Dhimant Desai, Shantu Amin, Stan Lightfoot & Levy Kopelovich. (2013) Chemopreventive Effects of the p53-Modulating Agents CP-31398 and Prima-1 in Tobacco Carcinogen-Induced Lung Tumorigenesis in A/J Mice. Neoplasia 15:9, pages 1018-1027.
Crossref
Aditi Gurkar, Kiki Chub & Sam Lee. 2013. DNA Repair and Cancer. DNA Repair and Cancer 372 425 .
Kotaro Saga & Yasufumi Kaneda. (2013) Virosome Presents Multimodel Cancer Therapy without Viral Replication. BioMed Research International 2013, pages 1-9.
Crossref
Timothy K. MacLachlan. 2013. Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics. Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics 259 285 .
Makako Yamanaka, Yuji Tada, Kiyoko Kawamura, Quanhai Li, Shinya Okamoto, Kuan Chai, Sana Yokoi, Min Liang, Toshihiko Fukamachi, Hiroshi Kobayashi, Naoto Yamaguchi, Atsushi Kitamura, Hideaki Shimada, Kenzo Hiroshima, Yuichi Takiguchi, Koichiro Tatsumi & Masatoshi Tagawa. (2012) E1B-55 kDa-Defective Adenoviruses Activate p53 in Mesothelioma and Enhance Cytotoxicity of Anticancer Agents. Journal of Thoracic Oncology 7:12, pages 1850-1857.
Crossref
JIE-TAO MA, CHENG-BO HAN, JIAN-ZHU ZHAO, WEI JING, YANG ZHOU, LE-TIAN HUANG & HUA-WEI ZOU. (2012) Synergistic cytotoxic effects of recombinant human adenovirus p53 and radiation at various time points in A549 lung adenocarcinoma cells. Oncology Letters 4:3, pages 529-533.
Crossref
Ping-Jie Xiao, Thomas B Lentz & R Jude Samulski. (2012) Recombinant adeno-associated virus: clinical application and development as a gene-therapy vector. Therapeutic Delivery 3:7, pages 835-856.
Crossref
Qi Xie, Bi-Ling Liang, Yan-Heng Wu, Jing Zhang, Ming-Wang Chen, Hong-Yan Liu, Xiong-Fei Gu & Jin Xu. (2012) Synergistic anticancer effect of rAd/P53 combined with 5-fluorouracil or iodized oil in the early therapeutic response of human colon cancer in vivo. Gene 499:2, pages 303-308.
Crossref
Charles Lu, David J. Stewart, J. Jack Lee, Lin Ji, Rajagopal Ramesh, Gitanjali Jayachandran, Maria I. Nunez, Ignacio I. Wistuba, Jeremy J. Erasmus, Marshall E. Hicks, Elizabeth A. Grimm, James M. Reuben, Veerabhadran Baladandayuthapani, Nancy S. Templeton, John D. McMannis & Jack A. Roth. (2012) Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans. PLoS ONE 7:4, pages e34833.
Crossref
Xin Lu. 2012. Recent Advances in Cancer Research and Therapy. Recent Advances in Cancer Research and Therapy 197 213 .
Jennifer L. Hsu, Chi-Hong Chao, Xiaoming Xie & Mien-Chie Hung. 2012. Recent Advances in Cancer Research and Therapy. Recent Advances in Cancer Research and Therapy 113 133 .
A G Bader, D Brown, J Stoudemire & P Lammers. (2011) Developing therapeutic microRNAs for cancer. Gene Therapy 18:12, pages 1121-1126.
Crossref
Phong Trang, Jason F Wiggins, Christopher L Daige, Chris Cho, Michael Omotola, David Brown, Joanne B Weidhaas, Andreas G Bader & Frank J Slack. (2011) Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice. Molecular Therapy 19:6, pages 1116-1122.
Crossref
Man-Jeong Paik, Woo-Young Shim, Seung-Min Moon, Yeon-Mi Kim, Dong-Wan Kim, Kyoung-Rae Kim, Sun-A Kim, Jeom-Soon Shim, Sang-Dun Choi & Gwang Lee. (2011) Altered Amino Acid Metabolic Patterns in the Plasma of Rat Models with Adenovirus Infection. Bulletin of the Korean Chemical Society 32:5, pages 1569-1574.
Crossref
Célia Floquet, Jules Deforges, Jean-Pierre Rousset & Laure Bidou. (2011) Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides. Nucleic Acids Research 39:8, pages 3350-3362.
Crossref
Jian-Ying Chuang & Jan-Jong Hung. (2011) Overexpression of HDAC1 induces cellular senescence by Sp1/PP2A/pRb pathway. Biochemical and Biophysical Research Communications 407:3, pages 587-592.
Crossref
Yongxing Wang, Young-Ah Suh, Maren Y. Fuller, James G. Jackson, Shunbin Xiong, Tamara Terzian, Alfonso Quintás-Cardama, James A. Bankson, Adel K. El-Naggar & Guillermina Lozano. (2011) Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation. Journal of Clinical Investigation 121:3, pages 893-904.
Crossref
Anna MandinovaSam W. Lee. (2011) The p53 Pathway as a Target in Cancer Therapeutics: Obstacles and Promise. Science Translational Medicine 3:64.
Crossref
Kaveh Asadi-Moghaddam & E. Antonio Chiocca. 2011. Youmans Neurological Surgery. Youmans Neurological Surgery 1188 1196 .
James N. Warnock, Claire Daigre & Mohamed Al-Rubeai. 2011. Viral Vectors for Gene Therapy. Viral Vectors for Gene Therapy 1 25 .
Hiroyuki Nakai. 2011. Molecular Pathology of Liver Diseases. Molecular Pathology of Liver Diseases 343 370 .
Andreas G. Bader, David Brown & Matthew Winkler. (2010) The Promise of MicroRNA Replacement Therapy. Cancer Research 70:18, pages 7027-7030.
Crossref
Ryo Sakai, Shunsuke Kagawa, Yasumoto Yamasaki, Toru Kojima, Futoshi Uno, Yuuri Hashimoto, Yuichi Watanabe, Yasuo Urata, Noriaki Tanaka & Toshiyoshi Fujiwara. (2010) Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer. Molecular Cancer Therapeutics 9:6, pages 1884-1893.
Crossref
Zhen Wang & Yi Sun. (2010) Targeting p53 for Novel Anticancer Therapy. Translational Oncology 3:1, pages 1-12.
Crossref
Ken-ichiro IWAMI, Atsushi NATSUME & Toshihiko WAKABAYASHI. (2010) Gene Therapy for High-Grade Glioma. Neurologia medico-chirurgica 50:9, pages 727-736.
Crossref
Atsushi ITO, Hisako NAKANO & Kunio SHINOHARA. (2010) Role of Wild-type p53 in Apoptotic and Non-Apoptotic Cell Death Induced by X-irradiation and Heat Treatment in p53-mutated Mouse M10 Cells. Journal of Radiation Research 51:6, pages 665-673.
Crossref
Steve H. Thorne. (2010) Enhancing biological therapy through conditional regulation of protein stability. Expert Reviews in Molecular Medicine 12.
Crossref
ELIZABETH G. RHEE & DAN H. BAROUCH. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2027 2033 .
John Nemunaitis, Gary Clayman, Sanjiv S. Agarwala, William Hrushesky, James R. Wells, Charles Moore, John Hamm, George Yoo, Jose Baselga, Barbara A. Murphy, Kerstin A. Menander, Laura L. Licato, Sunil Chada, Robert D. Gibbons, Magali Olivier, Pierre Hainaut, Jack A. Roth, Robert E. Sobol & W. Jarrard Goodwin. (2009) Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck . Clinical Cancer Research 15:24, pages 7719-7725.
Crossref
Sandra Kraljević Pavelić, Marko Marjanović, Miroslav Poznić & Marijeta Kralj. (2009) Adenovirally mediated p53 overexpression diversely influence the cell cycle of HEp-2 and CAL 27 cell lines upon cisplatin and methotrexate treatment. Journal of Cancer Research and Clinical Oncology 135:12, pages 1747-1761.
Crossref
Jian‐Ying Chuang, Chien‐Hsing Wu, Ming‐Derg Lai, Wen‐Chang Chang & Jan‐Jong Hung. (2009) Overexpression of Sp1 leads to p53‐dependent apoptosis in cancer cells. International Journal of Cancer 125:9, pages 2066-2076.
Crossref
Emma Bolderson, Derek J. Richard, Bin-Bing S. Zhou & Kum Kum Khanna. (2009) Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair. Clinical Cancer Research 15:20, pages 6314-6320.
Crossref
Roshini M Ponnamperuma, Kathryn E King, Tamador Elsir, Adam B Glick, Geoffrey M Wahl, Monica Nister & Wendy C Weinberg. (2009) The transcriptional regulatory function of p53 is essential for suppression of mouse skin carcinogenesis and can be dissociated from effects on TGF-β-mediated growth regulation. The Journal of Pathology 219:2, pages 263-274.
Crossref
Kaveh Asadi-Moghaddam & E. Antonio Chiocca. (2009) Gene- and viral-based therapies for brain tumors. Neurotherapeutics 6:3, pages 547-557.
Crossref
Angelina V. Vaseva & Ute M. Moll. (2009) The mitochondrial p53 pathway. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1787:5, pages 414-420.
Crossref
Toshiyuki Amano, Akira Nakamizo, Sandip K. Mishra, Joy Gumin, Naoki Shinojima, Raymond Sawaya & Frederick F. Lang. (2009) Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptosis in human glioma cells by increasing expression of pro-apoptotic genes. Journal of Neuro-Oncology 92:3, pages 357-371.
Crossref
Philip Savage, Justin Stebbing, Mark Bower & Tim Crook. (2008) Why does cytotoxic chemotherapy cure only some cancers?. Nature Clinical Practice Oncology 6:1, pages 43-52.
Crossref
Kristoffer Valerie & Paul R. Graves. 2009. The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies. The Impact of Tumor Biology on Cancer Treatment and Multidisciplinary Strategies 313 321 .
Jackie M NemunaitisJohn Nemunaitis. (2008) Potential of Advexin ® : a p53 gene-replacement therapy in Li–Fraumeni syndrome . Future Oncology 4:6, pages 759-768.
Crossref
Padmaja Magadala & Mansoor Amiji. (2008) Epidermal Growth Factor Receptor-Targeted Gelatin-Based Engineered Nanocarriers for DNA Delivery and Transfection in Human Pancreatic Cancer Cells. The AAPS Journal 10:4.
Crossref
Alexei Vazquez, Elisabeth E. Bond, Arnold J. Levine & Gareth L. Bond. (2008) The genetics of the p53 pathway, apoptosis and cancer therapy. Nature Reviews Drug Discovery 7:12, pages 979-987.
Crossref
Qi Xie, Biling Liang, Jing Zhang, Qihua Yang, Xiongfei Gu, Jing Xu & Mingwang Chen. (2008) In vivo comparison of transduction efficiency with recombinant adenovirus-mediated p53 in a human colon cancer mouse model by different delivery routes. The Chinese-German Journal of Clinical Oncology 7:12, pages 704-708.
Crossref
Changqing Su, Hui Cao, Shuping Tan, Yao Huang, Xiaoyuan Jia, Lixin Jiang, Kai Wang, Ying Chen, Ju Long, Xinyuan Liu, Mengchao Wu, Xiaobing Wu & Qijun Qian. (2008) Toxicology Profiles of a Novel p53-Armed Replication-Competent Oncolytic Adenovirus in Rodents, Felids, and Nonhuman Primates. Toxicological Sciences 106:1, pages 242-250.
Crossref
Yasuo Yoshioka, Ratima Asavatanabodee, Yusuke Eto, Hikaru Watanabe, Tomohiro Morishige, Xinglei Yao, Shinya Kida, Mitsuko Maeda, Yohei Mukai, Hiroyuki Mizuguchi, Koichi Kawasaki, Naoki Okada & Shinsaku Nakagawa. (2008) Tat conjugation of adenovirus vector broadens tropism and enhances transduction efficiency. Life Sciences 83:21-22, pages 747-755.
Crossref
Jim O'Prey, Simon Wilkinson & Kevin M. Ryan. (2008) Tumor Antigen LRRC15 Impedes Adenoviral Infection: Implications for Virus-Based Cancer Therapy. Journal of Virology 82:12, pages 5933-5939.
Crossref
Andreas C. JoergerAlan R. Fersht. (2008) Structural Biology of the Tumor Suppressor p53. Annual Review of Biochemistry 77:1, pages 557-582.
Crossref
Hui-Wen Lo, Lisa Stephenson, Xinyu Cao, Mira Milas, Raphael Pollock & Francis Ali-Osman. (2008) Identification and Functional Characterization of the Human Glutathione S-Transferase P1 Gene as a Novel Transcriptional Target of the p53 Tumor Suppressor Gene . Molecular Cancer Research 6:5, pages 843-850.
Crossref
Roy Bastien, Tracey B. Lewis, Jason E. Hawkes, John F. Quackenbush, Thomas C. Robbins, Juan Palazzo, Charles M. Perou & Philip S. Bernard. (2008) High-throughput amplicon scanning of the TP53 gene in breast cancer using high-resolution fluorescent melting curve analyses and automatic mutation calling. Human Mutation 29:5, pages 757-764.
Crossref
T Kidokoro, C Tanikawa, Y Furukawa, T Katagiri, Y Nakamura & K Matsuda. (2007) CDC20, a potential cancer therapeutic target, is negatively regulated by p53. Oncogene 27:11, pages 1562-1571.
Crossref
Atsuko Fujihara, Masayuki Kurooka, Tsuneharu Miki & Yasufumi Kaneda. (2007) Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation. Cancer Immunology, Immunotherapy 57:1, pages 73-84.
Crossref
Ulrich R. Hengge. 2008. Grundlagen der Molekularen Medizin. Grundlagen der Molekularen Medizin 379 394 .
Christian Klein & Lyubomir T. Vassilev. 2008. Checkpoint Responses in Cancer Therapy. Checkpoint Responses in Cancer Therapy 19 56 .
Jingwu Xie. 2008. Sunlight, Vitamin D and Skin Cancer. Sunlight, Vitamin D and Skin Cancer 241 251 .
Quanhong Sun, Tsukasa Sakaida, Wen Yue, Susanne M. Gollin & Jian Yu. (2007) Chemosensitization of head and neck cancer cells by PUMA. Molecular Cancer Therapeutics 6:12, pages 3180-3188.
Crossref
Joanne T. Douglas. (2007) Adenoviral vectors for gene therapy. Molecular Biotechnology 36:1, pages 71-80.
Crossref
Neil Senzer, John Nemunaitis, Michael Nemunaitis, Jeffrey Lamont, Martin Gore, Hani Gabra, Rosalind Eeles, Nayanta Sodha, Frank J. Lynch, Louis A. Zumstein, Kerstin B. Menander, Robert E. Sobol & Sunil Chada. (2007) p53 therapy in a patient with Li-Fraumeni syndrome . Molecular Cancer Therapeutics 6:5, pages 1478-1482.
Crossref
Lori J. Kornberg & Maria B. Grant. (2007) Adenoviruses increase endothelial cell proliferation, migration, and tube formation: Partial reversal by the focal adhesion kinase inhibitor, FRNK. Microvascular Research 73:3, pages 157-162.
Crossref
Kun-Xian Shu, Biao Li & Li-Xiang Wu. (2007) The p53 network: p53 and its downstream genes. Colloids and Surfaces B: Biointerfaces 55:1, pages 10-18.
Crossref
Michael B. Kastan. (2007) Wild-Type p53: Tumors Can't Stand It. Cell 128:5, pages 837-840.
Crossref
Józefa Węsierska-Gądek, M. Lienhard Schmitz & Carmen Ranftler. (2007) Roscovitine-activated HIP2 kinase induces phosphorylation of wt p53 at Ser-46 in human MCF-7 breast cancer cells. Journal of Cellular Biochemistry 100:4, pages 865-874.
Crossref
B A Guinn, J S Norris, F Farzaneh & A B Deisseroth. (2006) International Society for Cell and Gene Therapy of Cancer: 2005 meeting in Shenzhen, China. Cancer Gene Therapy 14:2, pages 128-138.
Crossref
Sunil Chada & Rajagopal Ramesh. (2007) Apoptin studies illuminate intersection between lipidomics and tumor suppressors. Molecular Therapy 15:1, pages 7-9.
Crossref
G Palacios & U M Moll. (2006) Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo. Oncogene 25:45, pages 6133-6139.
Crossref
K B Spurgers, N S Chari, N L Bohnenstiehl & T J McDonnell. (2006) Molecular mediators of cell death in multistep carcinogenesis: a path to targeted therapy. Cell Death & Differentiation 13:8, pages 1360-1370.
Crossref
Vladimir V Ternovoi, David T Curiel, Bruce F Smith & Gene P Siegal. (2006) Adenovirus-mediated p53 tumor suppressor gene therapy of osteosarcoma. Laboratory Investigation 86:8, pages 748-766.
Crossref
Charles H Yang & Massimo Cristofanilli. (2006) The role of p53 mutations as a prognostic factor and therapeutic target in inflammatory breast cancer . Future Oncology 2:2, pages 247-255.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.